Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate dose optimization and safety study for postoperative mechanically ventilated ICU patients
ChiCTR2100043752Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in None, sponsored by Union Hospital. Primary endpoints: Single intravenous injection dose of remimazolam tosilate and Continuous intravenous pump dose of remimazolam tosilate. Started Jan 2021; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2100043752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043752.